LIVN Q3 2024 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$318M+11.2% YoY

Gross Profit

$225M70.8% margin

Operating Income

$36M11.2% margin

Net Income

$33M10.4% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

-0.1%

Cash Flow

Operating Cash Flow

$51M

Free Cash Flow

$33M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.2B

Stockholders' Equity

$1.3B

Cash & Equivalents

$346M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$318M	$286M	+11.2%
Gross Profit	$225M	$202M	+11.6%
Operating Income	$36M	$4M	+699.0%
Net Income	$33M	-$7M	+550.3%

Revenue Segments

Cardiopulmonary Segment

$172M55%

Neuromodulation Segment

$140M45%

Geographic Segments

UNITED STATES

$180M57%

Locations Excluding The United States And Europe

$85M27%

Europe

$53M17%